MOLBIZ is a full service provider since 2013 and offers a digital analysis platform from NanoString (nCounter technology) for the detection of protein, DNA, miRNA, and mRNA. We also offer an in vitro diagnostic application for patients with breast cancer (Prosigna ®).
Dashboard
Publication:
ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology.
Walter RF, Werner R, Vollbrecht C, Hager T, Flom E, Christoph DC, Schmeller J, Schmid KW, Wohlschlaeger J, Mairinger FD: ACTB, CDKN1B,
GAPDH, GRB2, RHOA
and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology. PLoS One. 2016 Nov 1;11(11):e0165181. doi: 10.1371/journal.pone.0165181
Publication:
Massive parallel sequencing and digital gene expression analysis reveals potential mechanisms to overcome therapy resistance in pulmonary neuroendocrine tumors.
Walter RF, Vollbrecht C, Christoph D, Werner R, Schmeller J, Flom E, Trakada G, Rapti A, Adamidis V, Hohenforst-Schmidt W, Kollmeier J, Mairinger T, Wohlschlaeger J, Zarogoulidis P, Porpodis K, Schmidt KW, Mairinger FD: Massive parallel sequencing and digital gene expression analysis reveals potential mechanisms to overcome therapy resistance in pulmonary neuroendocrine tumors. J Cancer. 2016 Oct 25;7(15):2165-2172.